Outcomes and Safety of Very-Low-Dose Edoxaban in Frail Patients With Atrial Fibrillation in the ELDERCARE-AF Randomized Clinical Trial

IMPORTANCE: The prevalence of atrial fibrillation (AF) increases with age and is more common in frail patients. However, data are lacking on outcomes of oral anticoagulants (OACs) in very elderly patients with AF with frailty, who are ineligible for standard anticoagulant treatment. OBJECTIVE: To co...

Descripción completa

Detalles Bibliográficos
Autores principales: Akashi, Shintaro, Oguri, Mitsutoshi, Ikeno, Eiichiro, Manita, Mamoru, Taura, Junki, Watanabe, Saori, Hayashi, Takuya, Akao, Masaharu, Okumura, Ken, Akishita, Masahiro, Yamashita, Takeshi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Medical Association 2022
Materias:
Original Investigation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9399878/
https://www.ncbi.nlm.nih.gov/pubmed/35997978
http://dx.doi.org/10.1001/jamanetworkopen.2022.28500

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9399878/
https://www.ncbi.nlm.nih.gov/pubmed/35997978
http://dx.doi.org/10.1001/jamanetworkopen.2022.28500

Ejemplares similares